Cargando…
Human mobility and coronavirus disease 2019 (COVID-19): a negative binomial regression analysis
OBJECTIVES: This study aimed to examine the link between human mobility and the number of coronavirus disease 2019 (COVID-19)–infected people in countries. STUDY DESIGN: Our data set covers 144 countries for which complete data are available. To analyze the link between human mobility and COVID-19–i...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society for Public Health. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351378/ https://www.ncbi.nlm.nih.gov/pubmed/32739776 http://dx.doi.org/10.1016/j.puhe.2020.07.002 |
Sumario: | OBJECTIVES: This study aimed to examine the link between human mobility and the number of coronavirus disease 2019 (COVID-19)–infected people in countries. STUDY DESIGN: Our data set covers 144 countries for which complete data are available. To analyze the link between human mobility and COVID-19–infected people, our study focused on the volume of air travel, the number of airports, and the Schengen system. METHODS: To analyze the variation in COVID-19–infected people in countries, we used negative binomial regression analysis. RESULTS: Our findings suggest a positive relationship between higher volume of airline passenger traffic carried in a country and higher numbers of patients with COVID-19. We further found that countries which have a higher number of airports are associated with higher number of COVID-19 cases. Schengen countries, countries which have higher population density, and higher percentage of elderly population are also found to be more likely to have more COVID-19 cases than other countries. CONCLUSIONS: The article brings a novel insight into the COVID-19 pandemic from a human mobility perspective. Future research should assess the impacts of the scale of sea/bus/car travel on the epidemic. The findings of this article are relevant for public health authorities, community and health service providers, as well as policy-makers. |
---|